Immune Response to High-Dose vs. Standard Dose Influenza Vaccine

Clinical trial NCT02297542 · UNKNOWN

Trial details

NCT number: NCT02297542
Sponsor: Health Sciences North Research Institute
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Elderly Immune System

Start date: 2014-10-01
Primary completion: 2019-12-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.